Uterine Fibroids
Chuanyong Lu
Qiang Liu
<p>My research interests include pancreatic and colonic carcinogenesis and causes of fatty liver disease. Clinical expertise is in the area of gastrointestinal and liver pathology including liver transplantation. </p>
Ken Yu Lin
Radical cancer surgery and minimally invasive surgery using laparoscopy and the da Vinci robotic platform
The long-term objective of Dr. Lin’s research is to develop immunotherapy and biomarker-driven targeted therapy for gynecologic cancers.
<p>Ken Yu Lin, MD, is an Associate Professor, Obstetrics & Gynecology and Women’s Health at Montefiore Einstein. He provides comprehensive, compassionate evidence-based care for women with gynecologic cancers. Dr. Lin performs radical cancer surgery and minimally invasive surgery using laparoscopy and the da Vinci robotic platform.</p><p>After obtaining his Bachelor of Science in chemistry from Stanford University in 1997, Dr. Lin earned his Doctor of Philosophy in biochemistry and cell and molecular biology at Johns Hopkins University in 2006, where he performed research in tumor immunology. He received his Doctor of Medicine at Northwestern University in 2007 before completing an obstetrics & gynecology residency at Yale-New Haven Hospital in 2011. He then completed his gynecologic oncology fellowship at the University of Texas Southwestern Medical Center in 2015.</p><p>The long-term objective of Dr. Lin’s research is to develop immunotherapy and biomarker-driven targeted therapy for gynecologic cancers. Through his collaborations with biomedical scientists and participation in NRG Oncology, Dr. Lin’s research spans several areas. These include developing immunotherapy for ovarian cancer, the biology of uterine serous carcinoma and developing therapy for gynecologic cancers of less common histology, particularly ovarian clear cell carcinoma and carcinosarcoma. His work has been published in numerous peer-reviewed journals, books, chapters, articles and abstracts, including <em>Cancer Research</em>, <em>Cell</em>, and <em>Science Translational Medicine</em>.</p><p>Dr. Lin is board certified in Obstetrics & Gynecology and Gynecologic Oncology and is a member of the Society of Gynecologic Oncology. He participated in the Reproductive Scientist Development Program (RSDP) from 2015 to 2018 and won the Gynecological Oncology Group (GOG) Foundation Early Investigator Award in 2019. He serves on the NRG Oncology Rare Tumor Committee.</p>
Harry J. Lieman
<p>Areas of interest:</p>
<p>Polycystic Ovary Syndrome (PCOS),<em> in vitro</em> fertilization (IVF), Preimplantation Genetic Diagnosis and Screening (PGD/PGS), minimally invasive surgery to repair the uterus and fallopian tubes and Reproductive Ethics and Jewish Law. </p>
<p>Dr. Lieman is the medical director of Montefiore's Institute for Reproductive Medicine and Health located in Hartsdale, NY. He also is the chairman of the Reproductive Bioethics Committee at the Albert Einstein College of Medicine and recently was appointed as a member of Yeshiva University's Program for Jewish Genetic Health as the liaison for Fertility and Reproductive Technologies.</p>
<p>Dr. Lieman has participated in clinical research in women with Polycystic Ovary Syndrome and has presented nationally on this topic. He currently is on faculty at Yeshiva University’s Center for the Jewish Future and has been actively lecturing rabbis about infertility and the intricate details of the clinical evaluation of the infertile couple and the clinical and laboratory techniques available to promote conception. He is an ATIME medical advisor and he also is working clinically and academically with the PUAH Institute in Jerusalem (Fertility and Medicine according to Halacha) and has presented collaborative data at international meetings. Dr. Lieman completed his undergraduate training at Yeshiva University. He received his medical degree from the State University of New York Health Science Center in Brooklyn (“Downstate Medical Center”) and then completed his residency training in Obstetrics and Gynecology at the Albert Einstein College of Medicine. After residency, he completed a fellowship in Reproductive Endocrinology and Infertility at the University of Medicine and Dentistry in New Jersey-New Jersey Medical School. He is board certified in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility.</p>
Dr. Lieman’s clinical focus is polycystic ovary syndrome (PCOS),<em> in vitro</em> fertilization (IVF), and preimplantation genetic testing (PGT). His interests also include third-party reproduction including oocyte, sperm and embryo donation, fertility preservation and minimally invasive surgery to repair the uterus and fallopian tubes.
Dr. Lieman’s research interests include PCOS and fertility treatment outcome studies. His most recent studies have used the annual Society for Assisted Reproductive Technology (SART) clinical summary report to assess various IVF treatments and results at a national level.
<p>Harry J. Lieman, MD, is the director of the Division of Reproductive Endocrinology, and Infertility, Medical Director of Montefiore’s Institute for Reproductive Medicine and Health and is the Reproductive Tissue Bank Medical Director for oocyte and sperm donation at Montefiore. He is also Professor of Obstetrics and Gynecology and Women’s Health at our Albert Einstein College of Medicine. Dr. Lieman’s clinical focus is polycystic ovary syndrome (PCOS),<em> in vitro</em> fertilization (IVF), and preimplantation genetic testing (PGT). His interests also include third-party reproduction including oocyte, sperm and embryo donation, fertility preservation and minimally invasive surgery to repair the uterus and fallopian tubes.</p><p>After receiving his Bachelor of Arts in biology from Yeshiva University in 1986, Dr. Lieman attended State University of New York- SUNY-Downstate in Brooklyn, earning his Doctor of Medicine in 1990. He began his postdoctoral education with a four-year residency in obstetrics and gynecology at Montefiore-Einstein, acting as administrative chief resident in his final year. He then pursued a fellowship in reproductive endocrinology and infertility at University of Medicine and Dentistry of New Jersey, completing the fellowship in 1996.</p><p>Dr. Lieman’s research interests include PCOS and fertility treatment outcome studies. His most recent studies have used the annual Society for Assisted Reproductive Technology (SART) clinical summary report to assess various IVF treatments and results at a national level. He has been an active contributor to his field of research, publishing journal articles, abstracts, book chapters and presenting at annual conferences and information sessions.</p><p>Dr. Lieman has been recognized several times by the American Society for Reproductive Medicine (ASRM) with STAR Awards for his many presentations at ASRM annual meetings. He has been listed in Top Doctors, New York Metro Area from 2014 through 2021. He is board certified in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility.</p>
Mark D. Levie
Javier A. Laurini
<span style="font-size:11.0pt;line-height:107%;font-family:'Calibri',sans-serif;">Dr. Laurini's clinical focus is on the study of tissue to diagnose inflammatory and neoplastic diseases of the breast, gynecologic tract and bone and soft tissues.</span>
<span style="font-size:11.0pt;line-height:107%;font-family:'Calibri',sans-serif;">Dr. Laurini's research focus follows his clinical interests in breast and gynecologic pathology.</span>
<p>Javier Ariel Laurini, MD, is Associate Professor, Pathology at Montefiore Einstein. Dr. Laurini's clinical focus is on the study of tissue to diagnose inflammatory and neoplastic diseases of the breast, gynecologic tract and bone and soft tissues.</p>
<p>After earning his Doctor of Medicine in 1995 from the University Of Salvador, School Of Medicine in Buenos Aires, Argentina, Dr. Laurini completed a residency in anatomic pathology in 1999 at the Center of Medical Education and Clinical Investigations (CEMIC) in Buenos Aires. Following this, he completed a three-month internship in hematopathology service at Massachusetts General Hospital. Dr. Laurini became Administrative Chief Resident in the department of pathology at CEMIC for one year before completing a surgical pathology fellowship at British Hospital in Buenos Aires in 2002. He then became a visiting clinician in the Department of Pathology, Mayo Clinic in Rochester before undergoing a combined anatomic and clinical pathology residency at the University of South Alabama College of Medicine, which he completed in 2010. Dr. Laurini then finished a fellowship in surgical pathology at the Mayo Clinic in 2011 before completing another fellowship in hematopathology at the University of Nebraska Medical Center in 2012.</p>
<p>Dr. Laurini's research focus follows his clinical interests in breast and gynecologic pathology. His work has been published in numerous original communications and peer-reviewed journals, articles and abstracts.</p>
<p>Dr. Laurini is board certified in Hematology and Anatomic and Clinical Pathology by the American Board Of Pathology. He is a Fellow of the College of American Pathologists and the American Society of Clinical Pathologists, and a member of the United States and Canadian Academy of Pathology. He is also part of the Mayo Clinic Alumni Association. Dr. Laurini has won multiple faculty teaching awards from the University of South Alabama and Wake Forest School of Medicine. In 2022 he won the Attending Teaching Award from Einstein.</p>
Susan D. Klugman
Non Invasive Prenatal Screening
Expanded Carrier Screening
Hereditary Cancer Syndromes
Jewish Genetics
Zika
Genetic Education
<p>Dr. Klugman is a "medical detective" who works to identify the possible genetic risk factors for many inherited diseases. She encourages couples to consider genetic testing even before they get married so they can be as informed as possible when planning their families. Dr. Klugman’s clinical focus is on the evaluation of patients and families at risk for genetic disorders during pregnancy or preconception, including prenatal diagnosis and consultation for patients undergoing assisted reproductive technologies. She also provides evaluations for patients at risk for hereditary cancer syndromes.
Dr. Klugman has appeared on ABC World News Tonight with Diane Sawyer and WABC-TV Ch. 7. She has also been profiled and quoted in numerous articles in the Westchester Journal News.</p>
Dr. Klugman’s clinical focus is on the evaluation of patients and families at risk for genetic disorders during pregnancy or preconception, including prenatal diagnosis and consultation for patients undergoing assisted reproductive technologies. She also provides evaluations for patients at risk for hereditary cancer syndromes.
Dr. Klugman’s research focuses on novel methods for prenatal screening, testing and diagnosis as well as the assessment of new modalities for diagnoses and treatment of hereditary cancer syndromes.
<p>Syeda M, Upadhyay K, Loke J, <strong>Klugman S</strong>, Pearlman A, Shao Y, Ostrer H,<em> Prediction of breast <em>cancer risk based on flow variant analysis of circulating peripheral blood B cells, </em>Genetics in Medicine, March 16, 2017</em></p>
<p>Aung C, Greb A, Kalia I, Bajaj K, <strong>Klugman S</strong>, <em>Patient Perspectives on Intimate Partner Violence Discussion during Genetic Counseling Sessions</em>, Journal of Genetic Counseling, December 9, 2016</p>
<p>Wiesman C, Rose E, Grant A, Zimlover A, <strong>Klugman S</strong>, Schreiber-Agus N, <em>Experiences from a pilot program bringing BRCA1/2 genetic screening to the U.S. Ashkenazi Jewish population - The BRCAcommunity Initiative: Results and Reflections from Year 1, </em>Genetics in Medicine, October 2016</p>
<p>Gregg A, Skotko BG, Benkendorf JL, Monaghan KG, Bajaj K, Best RG, <strong>Klugman S</strong>, Watson MS, <em>Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics</em>, Genetics in Medicine, October 18 2016</p>
<p>Shani H, Goldwaser T, Keating J, <strong>Klugman S, </strong><em>Chromosomal abnormalities not currently detected by cell-free fetal DNA: a retrospective analysis at a single center,</em> American Journal of Obstetrics and Gynecology, Jun 2016; 214(6):729.e1-729.</p>
<p>Rose E, Schreiber-Agus N, Bajaj K, <strong>Klugman S</strong>, Goldwaser T. <a href="http://www.ncbi.nlm.nih.gov/pubmed/26354339"><em>Challenges of Pre- and Post-Test Counseling for Orthodox Jewish Individuals in the Premarital Phase.</em></a> Journal of Genetic Counseling. 2016 Feb;25(1):18-24.</p>
<p>Wiesman C, Rose E, <strong>Klugman S</strong>, Schreiber-Agus N. <a href="http://www.ncbi.nlm.nih.gov/pubmed/26611540"><em>From Campers to Counselors: a Resource for Prospective Genetic Counseling Students.</em></a>Journal of Genetic Counseling. 2015 Nov 27</p>
<p>Ferraira, JC, Shreiber-Agus N, Carter SM, <strong>Klugman S,</strong> Grieg AR, Gross SJ <em>Carrier <em>testing for Ashkenazi Jewish disorders in the prenatal setting: navigating the genetic maze</em>, American Journal of Obstetrics & Gynecology, 2014 Sept (3) 194-204.</em></p>
<p><strong>Klugman S</strong>, Dolan SM. <em>Expanded genetic testing in assisted reproductive technology: lessons learned from prenatal testing</em>. Virtual Mentor 2014 Jan 1;(16)1: 38-42</p>
<p><strong>Klugman S, </strong>Suskin,B, Spencer B, Dar P, Bajaj K, Powers, J, Reichling J, Wasserman D, Dolan S, Merkatz I. <em>Clinical Utility of Chromosomal Microarray Analysis in Prenatal <em>Diagnosis: Report of First 6 Months in Clinical Practice </em>The Journal of Maternal-Fetal and Neonatal Medicine 2013 Nov 26</em></p>
<p><strong>Klugman S,</strong> Schreiber-Agus N, Nazareth S<strong>, </strong>Evans, E<em>Detection of Carriers in the Ashkenazi Jewish Population: An Objective Comparison of High-Throughput Genotyping vs Gene by Gene </em>Genetic Testing and Molecular Biomarkers 2013 Oct;17(10):763-7</p>
<p>Gutiérrez JF, Bajaj K, <strong>Klugman</strong><strong> </strong><strong>SD</strong>. <em>Prenatal screening for fragile x: carriers, controversies, and counseling. </em>Reviews in Obstetrics and Gynecology 2013;6(1):e1-7</p>
<p class="desc"><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Rinella%20ES%5BAuthor%5D&ca… ES</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Shao%20Y%5BAuthor%5D&cautho… Y</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Yackowski%20L%5BAuthor%5D&c… L</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Pramanik%20S%5BAuthor%5D&ca… S</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Oratz%20R%5BAuthor%5D&cauth… R</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Schnabel%20F%5BAuthor%5D&ca… F</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Guha%20S%5BAuthor%5D&cautho… S</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=LeDuc%20C%5BAuthor%5D&cauth… C</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Campbell%20CL%5BAuthor%5D&c… CL</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Klugman%20SD%5BAuthor%5D&ca…; <strong>SD</strong></a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Terry%20MB%5BAuthor%5D&caut… MB</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Senie%20RT%5BAuthor%5D&caut… RT</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Andrulis%20IL%5BAuthor%5D&c… IL</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Daly%20M%5BAuthor%5D&cautho… M</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=John%20EM%5BAuthor%5D&cauth… EM</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Roses%20D%5BAuthor%5D&cauth… D</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Chung%20WK%5BAuthor%5D&caut… WK</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Ostrer%20H%5BAuthor%5D&caut… H</a>. <em>Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation</em> Hum Genet 2013 May 132(5) 523-26.</p>
<p class="desc">Wapner RJ, Martin CL, Levy B, Ballif BC, Eng CM, Zachary JM, Savage M, Platt LD, Saltzman D, Grobman WA, <strong>Klugman S</strong>, Scholl T, Simpson JL, McCall K, Aggarwal VS, Bunke B, Nahum O, Patel A, Lamb AN, Thom EA, Beaudet AL, Ledbetter DH, Shaffer LG, Jackson L. <em>Chromosomal microarray versus karyotyping for prenatal diagnosis. </em>New England Journal of Medicine 2012 Dec 6:367(23) 2175-8</p>
<p>Robin,NH, Reid Sutton V, Caldwell J, Jackson J, Irons M, Demmer L, Byers P, Ellison J, Feldman J, Gross S, <strong>Klugman S</strong>, Adam A, Keppler-Noreuil K, Hopkin R, McCandless S, Sharer D, Wiesner G, Pyeritz R, Westerman J <em>The development and implementation of an <em>In-service exam for medical genetics residency programs. </em>Genetics in Medicine 2012 May 14 (5):552-7</em></p>
<p>Yachelevich N, Gittler JK, <strong>Klugman S</strong>, Feldman B, Martin J, Brooks SS, Dobkin C, Nolin SL. <em>Terminal deletions of the long arm of chromosome X that include the FMR1 gene in female patients: A case series.</em> American Journal of Medical Genetics A. 2011 Apr;155(4):870-4.</p>
<p class="desc">Gross, SJ, Bajaj K, Garry D, <strong>Klugman S</strong>, Karpel BM, Roe AM Wagner BJ, Zhan J, Apfelroth SD, Schreiber-Agus N: <em>Rapid and novel prenatal molecular assay for detecting aneuploides and microdeletion syndromes</em>. Prenatal Diagnosis 2011 31(3):259-66</p>
<p class="desc">Ram, KT, <strong>Klugman, SD</strong>: <em>Best practices: antenatal screening for Common genetic conditions other than aneuploidy</em>. Current Opinions in Obstetrics and Gynecology 2010 22(2):139-45 </p>
<p class="desc"><strong>Klugman, S,</strong> Gross, SJ: Ashkenazi Jewish screening in the twenty-first century. Obstetric and Gynecologic Clinics of North America 2010 37(1): 37-46 </p>
<p class="desc">Rybak, EA, Beviliacqua, K, Veit, CR, <strong>Klugman, SD</strong>, Santoro N: <em>Sibling and self ovum donation for sisters with an intermediate FMR1 mutation: what's a program to do. </em>Fertility and Sterility 2009 92(1): 394</p>
<p class="desc"><strong>Klugman, S</strong>, Gross SJ, Khabele D, Liang, J, Lopez-Jones, M, Gross, B, Cordero, DR, Reznik, S: <em>Expression of Keratin 8 and TNF-Related Apoptosis-I Inducing Ligand (TRAIL) in Down Syndrome Placentas</em>. Placenta 2008 29(4):382-4</p>
<p class="desc">Breathnach FM, Malone FD, Lambert-Messerlian G, Cuckle HS, Porter TF, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, <strong>Klugman S</strong>, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, TrippT, Bianchi DW, D’Alton ME; <em>First and second Trimester screening detection of aneuploides other than Down Syndrome.</em> Obstetrics and Gynecology 2007 110(3):651-7</p>
<p class="desc">Eddleman KA, Malone FD, Sullivan L, Dukes K, Berkowitz RL, KharbutliY, Porter TF, Luthy DA, Comstock CH, Saade GR, <strong>Klugman S</strong>, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR Wolfe HM, D’Alton ME. <em>Pregnancy loss rates after midtrimester Amniocentesis. </em>Obstetrics and Gynecology. 2006 108:1067-72</p>
<p>Lambert-Messerlian, G., Dugoff, L., Vidaver, J., Canick, J.A., Malone, F.D., Ball, R.H., Comstock, C.H., Nyberg, D.A., Saade, G., Eddleman, K., <strong>Klugman, S</strong>., Craigo, S.D., Timor-Tritsch, I.E., Carr, S.R., Wolfe, H.M. & D’Alton, M.E. (2006). <em>First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): A FASTER trial study.</em> Prenatal Diagnosis, 26(8):672-8.</p>
<p class="desc"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retriev… DR, Goldberg Y, Basel D, Kilpatrick MW, <strong>Klugman S</strong>, Tsipouras P, Gross S.</a><em>Prenatal sonographic diagnosis of Grebe syndrome.</em> Journal of Ultrasound in Medicine. 2006 (1):115-8</p>
<p>Cleary-Goldman J, Malone FD, Vidaver J, Ball RH, Nyberg DA, Comstock CH, Saade GR, Edelmann KA, <strong>Klugman S</strong>, Timor-Tritsch IE, Craigo SD, Carr SR, Wolfe HM, Bianchi DW, D’Alton M<em> Faster Consortium, “Impact of maternal age on obstetric outcome.” </em>Obstetrics and Gynecology 2005 Vol. 105(5 Pt 1):983-90</p>
<p>Susan Klugman, MD, FACOG, FACMG, is Director, Reproductive and Medical Genetics, Program Director, Medical Genetics and Genomics Residency and Professor, Obstetrics & Gynecology and Women’s Health and Pediatrics at Montefiore Einstein. Her clinical focus is on the evaluation of patients and families at risk for genetic disorders including those patients at risk for hereditary cancer syndromes. She also provides evaluations during pregnancy or preconception, including prenatal diagnosis and consultation for patients undergoing assisted reproductive technologies.</p><p>After completing her Bachelor of Science at Cornell University in 1984, Dr. Klugman attended New York University School of Medicine, earning her Doctor of Medicine in 1988. She pursued her postdoctoral training at Montefiore Einstein and Jacobi Medical Center, completing her obstetrics and gynecology residency in 1992 and serving as administrative chief resident in her final year. In 2002, she continued her medical training at Montefiore Einstein in medical genetics, completing the program in 2004.</p><p>Dr. Klugman’s research focuses on novel methods for prenatal screening, testing and diagnosis as well as the assessment of new modalities for the diagnosis and treatment of hereditary cancer syndromes. Her work has been published in peer-reviewed journals, book chapters and other print publications. She was the Reproductive Genetics Editor for <em>Genetics in Medicine</em> and has been a reviewer for journals such as the <em>American Journal of Medical Genetics, Obstetrics and Gynecology and Prenatal Diagnosis</em>. Dr. Klugman has spoken extensively at regional and national medical conferences, including more than 70 international and national invited presentations.</p><p>Dr. Klugman has served on the board of the American College of Medical Genetics since 2015 and will be President from 2023 to 2025. She has completed six-year terms on both the Committee on Genetics of the American Board of Obstetrics and Gynecology and the Residency Review Committee for Medical Genetics for the Accreditation Council of Graduate Medical Education. She is board certified in both obstetrics and gynecology and medical genetics and is listed in several medical directories including <em>Who’s Who in Medical Sciences Education</em>, <em>Who’s Who in Academic Medicine</em>, <em>New York Magazine</em> Best Doctors list, and Castle Connelly <em>How to Find the Best Metro Area Doctors</em>.</p>
Rubina S. Khokhar
Dr. Khokhar's clinical focus centers on teaching obstetrics & gynecology to medical students and residents.
<p>Rubina Shakil Khokhar, MD, is an attending physician and Assistant Professor, Obstetrics & Gynecology at Montefiore Einstein. She is also Clerkship Site Leader, Wakefield Campus for Medical Education-Ob/Gyn. Her clinical focus centers on teaching obstetrics & gynecology to medical students and residents.</p><p>After obtaining her Bachelor of Medicine and Bachelor of Surgery in 1987 from Nishtar Medical College in Multan, Pakistan, Dr. Khokhar completed her residency in obstetrics & gynecology at Nishtar Hospital in 1987. She then completed another residency in obstetrics & gynecology at Azad Jammu and Kashmir Hospital in Muzaffarabad, Pakistan, in 1991. Following this, Dr. Khokhar participated in an obstetrics & gynecology fellowship at Post-Graduate Institute in Lahore, Pakistan, completing it in 1992. Dr. Khokhar then came to New York Hospital Medical Center of Queens (Cornell University) to complete a residency in general surgery in 1999 before completing an additional residency in obstetrics & gynecology at Our Lady of Mercy Medical Center, University Hospital of New York Medical College in 2006.</p><p>Dr. Khokhar is board certified by the American Board of Obstetrics and Gynecology and is a member of the American College of Obstetric & Gynecology (ACOG). She speaks English, Hindi, Urdu, Punjabi and Medical Spanish. She has received accolades for excellence in teaching medical students, including recognition by the Leo M. Davidoff Society and receiving a certificate of appreciation for excellence in teaching from NY Medical College, 2003 – 2006.</p>
Julie R. Kaplan
<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">Dr. Kaplan has a special interest in prenatal care, contraception and colposcopy.</span>
<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">Dr. Kaplan's research interests include simulation model research and researching the long-term outcome of estrogenized endometrium in postmenopausal women.</span>
<p>Julie Kaplan, MD is an attending physician, Assistant Professor of Obstetrics & Gynecology and Women's Health and Medical Student OBGYN Associate Clerkship Director at Montefiore Einstein. She has a special interest in prenatal care, contraception and colposcopy.</p><p>After obtaining her Bachelor of Science in 2008 from Cornell University, Dr. Kaplan earned her Doctor of Medicine in 2012 at SUNY Downstate College of Medicine. She then came to Montefiore Einstein to complete an internship and residency in Obstetrics and Gynecology in 2016.</p><p>Her research interests include simulation model research and researching the long-term outcome of estrogenized endometrium in postmenopausal women. Her work has been published in the American Journal of Obstetrics and Gynecology.</p><p>Dr. Kaplan is board certified in Obstetrics and Gynecology and is a member of the American College of Obstetricians and Gynecologists.</p>